SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 271 filers reported holding SEATTLE GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $22,916,000 | +13.3% | 117,103 | -1.7% | 0.02% | +5.6% |
| Q2 2020 | $20,232,000 | +99.2% | 119,070 | +35.3% | 0.02% | +63.6% |
| Q1 2020 | $10,157,000 | -0.3% | 88,026 | -1.2% | 0.01% | +37.5% |
| Q4 2019 | $10,185,000 | -2.6% | 89,139 | -27.2% | 0.01% | -11.1% |
| Q3 2019 | $10,458,000 | +23.0% | 122,452 | -0.3% | 0.01% | +12.5% |
| Q2 2019 | $8,501,000 | -6.1% | 122,844 | -0.6% | 0.01% | 0.0% |
| Q1 2019 | $9,054,000 | +36.1% | 123,634 | +5.3% | 0.01% | +14.3% |
| Q4 2018 | $6,651,000 | -31.6% | 117,387 | -6.9% | 0.01% | -22.2% |
| Q3 2018 | $9,726,000 | +12.9% | 126,114 | -2.8% | 0.01% | +12.5% |
| Q2 2018 | $8,612,000 | +27.0% | 129,720 | +0.1% | 0.01% | +33.3% |
| Q1 2018 | $6,781,000 | +6.6% | 129,563 | +9.0% | 0.01% | 0.0% |
| Q4 2017 | $6,361,000 | +101.0% | 118,895 | +104.4% | 0.01% | +100.0% |
| Q3 2017 | $3,165,000 | -0.8% | 58,167 | -5.7% | 0.00% | 0.0% |
| Q2 2017 | $3,191,000 | -28.7% | 61,688 | -13.4% | 0.00% | -40.0% |
| Q1 2017 | $4,476,000 | +16.4% | 71,223 | -2.2% | 0.01% | 0.0% |
| Q4 2016 | $3,844,000 | -5.9% | 72,842 | -3.6% | 0.01% | 0.0% |
| Q3 2016 | $4,083,000 | +51.8% | 75,597 | +13.6% | 0.01% | +25.0% |
| Q2 2016 | $2,689,000 | +14.4% | 66,526 | -0.7% | 0.00% | +33.3% |
| Q1 2016 | $2,350,000 | -21.8% | 66,982 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $3,006,000 | +20.1% | 66,982 | +3.2% | 0.00% | 0.0% |
| Q3 2015 | $2,502,000 | +2.4% | 64,879 | +28.5% | 0.00% | 0.0% |
| Q2 2015 | $2,444,000 | +47.5% | 50,490 | +7.7% | 0.00% | +100.0% |
| Q1 2015 | $1,657,000 | +10.2% | 46,890 | +0.2% | 0.00% | 0.0% |
| Q4 2014 | $1,503,000 | -18.5% | 46,790 | -5.6% | 0.00% | -33.3% |
| Q3 2014 | $1,844,000 | -3.6% | 49,590 | -0.8% | 0.00% | 0.0% |
| Q2 2014 | $1,912,000 | -16.1% | 49,990 | 0.0% | 0.00% | -25.0% |
| Q1 2014 | $2,278,000 | +12.4% | 49,990 | -1.6% | 0.00% | 0.0% |
| Q4 2013 | $2,026,000 | -51.6% | 50,790 | -46.8% | 0.00% | -55.6% |
| Q3 2013 | $4,185,000 | +39.3% | 95,490 | 0.0% | 0.01% | +28.6% |
| Q2 2013 | $3,004,000 | – | 95,490 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |